We are live on ! Find out more
GD

Grandfield & Dodd Portfolio holdings

AUM $1.77B
1-Year Est. Return 23.43%
This Fund
S&P 500
This Quarter Est. Return
+0.79%
1 Year Est. Return
+23.43%
3 Year Est. Return
+55.25%
5 Year Est. Return
+78.92%
10 Year Est. Return
+317.48%
AUM
$1.02B
AUM Growth
+$4.67M
Cap. Flow
+$2.09M
Cap. Flow %
0.21%
Top 10 Hldgs %
30.27%
Holding
183
New
2
Increased
49
Reduced
56
Closed
6

Top Sells

Rank Stock Value
1
DOX icon
Amdocs
DOX
+$566K
2
SYK icon
Stryker
SYK
+$501K
3
MSFT icon
Microsoft
MSFT
+$415K
4
ARRY
Array Biopharma Inc
ARRY
+$369K
5
GS icon
Goldman Sachs
GS
+$321K

Sector Composition

Rank Sector Weight
1 Technology 25.57%
2 Healthcare 17.23%
3 Financials 11.97%
4 Consumer Staples 10.84%
5 Industrials 10.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AAPL icon
51
Apple
AAPL
$4.97T
$6.21M 0.61%
110,896
+348
+0.3% +$18.2K
AMGN icon
52
Amgen
AMGN
$209B
$5.83M 0.57%
30,132
-627
-2% -$120K
VOO icon
53
Vanguard S&P 500 ETF
VOO
$956B
$5.29M 0.52%
19,395
ALL icon
54
Allstate
ALL
$70.6B
$5.16M 0.51%
47,491
-200
-0.4% -$20.9K
DOX icon
55
Amdocs
DOX
$6.03B
$4.65M 0.46%
70,340
-8,810
-11% -$566K
PEP icon
56
PepsiCo
PEP
$196B
$4.39M 0.43%
32,005
+125
+0.4% +$16.6K
BLKB icon
57
Blackbaud
BLKB
$1.94B
$4.27M 0.42%
47,248
+9,890
+26% +$880K
VMC icon
58
Vulcan Materials
VMC
$36.8B
$3.98M 0.39%
26,332
-150
-0.6% -$21.2K
JPM icon
59
JPMorgan Chase
JPM
$916B
$3.92M 0.39%
33,308
+400
+1% +$45.2K
REGN icon
60
Regeneron Pharmaceuticals
REGN
$72.9B
$3.78M 0.37%
13,617
+2,019
+17% +$597K
COP icon
61
ConocoPhillips
COP
$144B
$3.75M 0.37%
65,832
DOV icon
62
Dover
DOV
$26.7B
$3.31M 0.33%
33,300
-100
-0.3% -$9.59K
MA icon
63
Mastercard
MA
$498B
$3.17M 0.31%
11,671
-300
-3% -$82.7K
DVN icon
64
Devon Energy
DVN
$51.3B
$3.12M 0.31%
129,523
+200
+0.2% +$5K
UNH icon
65
UnitedHealth
UNH
$382B
$3.04M 0.3%
13,965
PFE icon
66
Pfizer
PFE
$143B
$2.92M 0.29%
85,726
+580
+0.7% +$21.1K
MMM icon
67
3M
MMM
$91.8B
$2.77M 0.27%
20,142
-477
-2% -$66.7K
ADBE icon
68
Adobe
ADBE
$105B
$2.71M 0.27%
9,814
-677
-6% -$198K
AXP icon
69
American Express
AXP
$224B
$2.64M 0.26%
22,317
-388
-2% -$47.6K
KO icon
70
Coca-Cola
KO
$383B
$2.36M 0.23%
43,400
-500
-1% -$26.8K
WPP icon
71
WPP
WPP
$4.67B
$2.36M 0.23%
37,645
-4,795
-11% -$287K
DHR icon
72
Danaher
DHR
$138B
$2.33M 0.23%
18,217
JWN
73
DELISTED
Nordstrom
JWN
$2.32M 0.23%
68,941
-2,045
-3% -$62.4K
UNP icon
74
Union Pacific
UNP
$174B
$1.94M 0.19%
11,954
CL icon
75
Colgate-Palmolive
CL
$74.8B
$1.84M 0.18%
25,006
-500
-2% -$36.3K

Similar funds

Grandfield & Dodd's Q3 2019 Portfolio in Review

As of Q3 2019, Grandfield & Dodd held 183 positions worth $1.02B, up 0.46% from $1.01B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Trading was light in Q3 2019: portfolio turnover was 4.4%. Grandfield & Dodd opened 2 new positions and exited 6, leaving the 183-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 26% a quarter earlier, followed by Healthcare and Financials.

  • Grandfield & Dodd's largest Q3 2019 buy was iShares Russell 1000 Growth ETF: 5,832 shares worth $233K.
  • Grandfield & Dodd added most to Blackbaud in Q3 2019, an estimated $880K increase.
  • Grandfield & Dodd's biggest Q3 2019 reduction was Amdocs, cutting an estimated $566K.
  • Grandfield & Dodd fully exited Array Biopharma Inc in Q3 2019, selling an estimated $369K.
  • Grandfield & Dodd's ten largest holdings make up 30% of its $1.02B portfolio in Q3 2019.
  • Grandfield & Dodd opened 2 new positions and closed 6 in Q3 2019.
  • Grandfield & Dodd's portfolio value rose 0.46% quarter-over-quarter to $1.02B.

Based on Grandfield & Dodd's 13F filing for Q3 2019, filed 30 Oct 2019.